share_log

Dolby Laboratories Insiders Sold US$1.0m Of Shares Suggesting Hesitancy

Dolby Laboratories Insiders Sold US$1.0m Of Shares Suggesting Hesitancy

杜比實驗室內部人士出售了價值100萬美元的股份,表明有所猶豫
Simply Wall St ·  09/22 21:51

Many Dolby Laboratories, Inc. (NYSE:DLB) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

去年,許多杜比實驗室(紐交所:DLB)的內部人士拋售了他們的股票,這可能會引起公司股東的興趣。 在評估內部交易時,了解內部人士是在買入股票通常比了解他們是否正在賣出更有益,因爲後者可能會有很多解讀。 但是,當多名內部人士在特定時段拋售股票時,股東應該注意,因爲這可能是一個警示信號。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

雖然我們永遠不會建議投資者僅基於公司董事已經做出的決策而做出決策,但同時我們認爲完全忽略內部交易是愚蠢的。

Dolby Laboratories Insider Transactions Over The Last Year

過去一年,杜比實驗室內部交易情況

In the last twelve months, the biggest single sale by an insider was when the Senior VP & Chief Marketing Officer, Todd Pendleton, sold US$1.0m worth of shares at a price of US$81.69 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of US$73.26. So it may not tell us anything about how insiders feel about the current share price.

在過去的十二個月中,一名內部人士進行的最大單筆交易是高級副總裁兼首席營銷官託德·彭德爾頓(Todd Pendleton)以81.69美元的價格出售了價值100萬美元的股票。 一般來說,我們不喜歡看到內部人士拋售股票,但是售價越低,我們就越擔憂。 好消息是,這筆大交易價格遠高於當前73.26美元的價格。 因此,這可能對內部人員對當前股價的看法沒有任何指示。

All up, insiders sold more shares in Dolby Laboratories than they bought, over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

總體而言,過去一年內部人員在杜比實驗室拋售的股票比購買的要多。 您可以在下面的圖表中看到過去一年內部人員(公司和個人)的交易情況。 如果您點擊圖表,您可以看到所有個體交易,包括股價、個體和日期!

big
NYSE:DLB Insider Trading Volume September 22nd 2024
紐交所:DLb內幕交易量2024年9月22日

If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.

如果您和我一樣,您就不會錯過這個免費的小盤股票列表,這些股票不僅被內部人士購買,而且估值也很有吸引力。

Does Dolby Laboratories Boast High Insider Ownership?

杜比實驗室是否擁有高內部持股?

For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Dolby Laboratories insiders own about US$37m worth of shares. That equates to 0.5% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

對於普通股東來說,值得檢查公司內部持有多少股份。如果內部人員擁有公司的大量股份,我認爲這是一個好跡象。杜比實驗室內部人員擁有價值約3700萬美元的股份,相當於公司的0.5%。這種程度的內部持股是不錯的,但並沒有特別突出。這確實表明了一定程度的一致性。

What Might The Insider Transactions At Dolby Laboratories Tell Us?

杜比實驗室內部交易可以告訴我們什麼?

It doesn't really mean much that no insider has traded Dolby Laboratories shares in the last quarter. We don't take much encouragement from the transactions by Dolby Laboratories insiders. The modest level of insider ownership is, at least, some comfort. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

過去一個季度沒有內部人員交易杜比實驗室的股票並沒有太多意義。我們對杜比實驗室內部人員的交易並不太鼓舞。適度的內部持股水平至少提供了一些安慰。如果你和我一樣,你可能想考慮這家公司是會增長還是會縮水。幸運的是,你可以查看這份免費報告,了解分析師對其未來的預測。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您可能會在其他地方找到一項出色的投資。因此,請查看此免費的有趣公司列表。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論